Close Menu

NEW YORK (GenomeWeb) – Natera said after the close of the market on Wednesday that its third quarter 2016 revenues climbed 20 percent year over year. 

For the three months ended Sept. 30, the molecular diagnostics firm brought in $53.9 million in revenues compared to $44.9 million in Q3 2015, and beating analysts' average estimate of $48.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.